Pages that link to "Q33986661"
Jump to navigation
Jump to search
The following pages link to Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons (Q33986661):
Displaying 29 items.
- Recent progress in understanding subtype specific regulation of NMDA receptors by G Protein Coupled Receptors (GPCRs) (Q27006067) (← links)
- Regulation of NMDA receptors by the tyrosine kinase Fyn (Q27027479) (← links)
- Chronic cocaine disrupts mesocortical learning mechanisms (Q28081785) (← links)
- Dopamine and extinction: a convergence of theory with fear and reward circuitry (Q28302559) (← links)
- The regulation of N-methyl-D-aspartate receptors by Src kinase. (Q30010212) (← links)
- How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia (Q30439924) (← links)
- Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons (Q34675038) (← links)
- Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. (Q34806634) (← links)
- Regulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapses (Q34990075) (← links)
- Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures (Q36877182) (← links)
- Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex (Q36932540) (← links)
- Higher levels of phosphorylated Y1472 on GluN2B subunits in the frontal cortex of aged mice are associated with good spatial reference memory, but not cognitive flexibility (Q37219690) (← links)
- Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors. (Q37276714) (← links)
- Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment (Q37862242) (← links)
- Emerging drugs for schizophrenia (Q37874626) (← links)
- Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. (Q37947984) (← links)
- Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. (Q38177261) (← links)
- The Regulation of GluN2A by Endogenous and Exogenous Regulators in the Central Nervous System (Q38852012) (← links)
- Antagonism of Dopamine D2 Receptors Alters Phosphorylation of Fyn in the Rat Medial Prefrontal Cortex (Q38973011) (← links)
- Directional gating of synaptic plasticity by GPCRs and their distinct downstream signalling pathways. (Q41166495) (← links)
- Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors (Q41603544) (← links)
- Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administration (Q43085680) (← links)
- Reduced cortical neurotransmitter receptor complex levels in fetal Down syndrome brain (Q50211157) (← links)
- Fyn kinase-regulated NMDA receptor- and AMPA receptor-dependent pain sensitization in spinal dorsal horn of mice. (Q51757577) (← links)
- Identification of novel inhibitor targeting Fyn kinase using molecular docking analysis (Q91937990) (← links)
- Analysis of Synapses in Cerebral Organoids (Q92508943) (← links)
- Dopamine Receptor Activation Modulates the Integrity of the Perisynaptic Extracellular Matrix at Excitatory Synapses (Q92880862) (← links)
- Amphetamine activates non-receptor tyrosine kinase Fyn and stimulates ERK phosphorylation in the rat striatum in vivo (Q93006950) (← links)
- Gut neurotoxin p-cresol induces differential expression of GLUN2B and GLUN2A subunits of the NMDA receptor in the hippocampus and nucleus accumbens in healthy and audiogenic seizure-prone rats (Q95819741) (← links)